Microbial pathogenicity: A new approach to drug development

5Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Pathogenic microorganisms, particularly pathogenic bacteria that cause debilitating diseases, are considered a threat for human health and well-being. Infectious diseases are rampant, particularly in developing countries.However, there are many other deadly diseases, such as cancer, diabetes, cardiac malfunction, etc., that account for significant loss of life and trauma in our society. In this article, I try to describe the role certain bacterial pathogens with long term residence in the human body can play in providing us with our next generation anticancer and other drugs, demonstrating that a certain amount of good can come out of such bacterial pathogens as well.

Cite

CITATION STYLE

APA

Chakrabarty, A. M. (2014). Microbial pathogenicity: A new approach to drug development. Advances in Experimental Medicine and Biology, 808, 41–49. https://doi.org/10.1007/978-81-322-1774-9_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free